Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
PAVmed Stock Quote

PAVmed (NASDAQ: PAVM)

$1.78
(0.6%)
$0.01
Price as of April 26, 2024, 12:09 p.m. ET

PAVmed Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
PAVM -70.76% -89.37% -36.12% -99%
S&P +24.47% +71.72% +11.41% +133%

PAVmed Company Info

PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. Its products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. The company was founded on June 26, 2014 and is headquartered in New York, NY.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.